跳至主要内容
临床试验/ISRCTN57309858
ISRCTN57309858已完成未知

What is the clinical and cost effectiveness of oral steroids in the treatment of acute lower respiratory tract infection (LRTI)? A placebo controlled randomised trial

niversity of Bristol (UK)0 个研究点目标入组 436 人开始时间: 2013年1月31日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
436

研究概览

简要总结

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged 18 years or over
  • 2. Consulting for an acute (<= 28 days) cough as the main presenting symptom
  • 3. In the past 24 hours, the patient has had at least one of the screening symptoms listed below (a-d), localizing to the lower respiratory tract and suggestive of an acute lower respiratory tract infection (RTI):
  • 3.1. Phlegm (sputum)
  • 3.2. Chest pain
  • 3.3. Shortness of breath
  • 3.4. Wheeze
  • 4. Patient and practice have sufficient time for consent and randomisation into the trial by the end of today
  • 5. Patient able and willing to give informed consent themselves
  • 6. Patient able and willing to complete the daily symptom diary themselves
  • 7. Patient able and willing to receive weekly telephone calls from the trial team

排除标准

  • 1. Known lung cancer or chronic lung disease (e.g. cystic fibrosis, COPD, bronchiectasis)
  • 2. Has an 'active' diagnosis of asthma (for which any treatment has been given in the past 5 years)
  • 3. The patient's RTI warrants same day hospital admission or immediate antibiotics (NB: use of delayed prescription does not preclude OSAC trial participation):
  • According to NICE guidelines, the patient warrants immediate antibiotic treatment by virtue of ONE OR MORE of the following:
  • 1. Is clinically very unwell or has symptoms and signs suggestive of pneumonia, e.g. tachypnoea (>20bpm), unilateral chest signs or consolidation, or hypoxia (oxygen saturation <94%) or other systemic infection, e.g. suspected bacteraemia OR
  • 2. Is at high risk of complications, including patients with chronic heart, chronic lung (e.g. COPD, bronchiectasis and cystic fibrosis), chronic renal, chronic liver or neuromuscular disease or immunosuppression; or with complications from previous episodes of lower respiratory tract infection, e.g. hospital admission for pneumonia OR
  • Aged over 65 years with at least TWO of the following criteria, or aged over 80 years with at least ONE of the following criteria:
  • 1. Unplanned hospitalisation within the previous year
  • 2. Type 1 or Type 2 diabetes
  • 3. History of cardiac failure
  • 4. Requires an antibiotic today to treat another infection unrelated to their acute cough, e.g. a co-existing cellulitis
  • 5. Recently (<=1 month) used inhaled corticosteroids
  • 6. Recently (<=1 month) used short (up to 2 weeks) course systemic corticosteroids
  • 7. Currently using, or has previously (<=12 months) used systemic steroids for a cumulative period greater than 2 weeks, i.e. 'long-term' use
  • 8. Known to be pregnant, is trying to conceive or is at risk of pregnancy (e.g. unwilling to take a reliable form of contraception) in the next month
  • 9. Currently breast-feeding
  • 10. This is not the patient's usual practice, i.e. patient is visiting or is not intending to stay with the practice for the 3 month trial follow up period
  • 11. Previously randomised in the OSAC trial
  • 12. Has been involved in another medicinal trial within the last 90 days or any other clinical research study within the last 30 days
  • 13. Is unable to give informed consent or complete the trial paperwork (including the symptom diary) through mental incapacity, e.g. major current psychiatric illness, learning difficulties and dementia
  • 14. Known immune-deficiency, e.g. chemotherapy causing immunosuppression, asplenia or splenic dysfunction, advanced cancer or HIV infection
  • 15. Has any of the following known contra-indications or cautions to oral steroids current OR previous history of:
  • 15.1. Peptic ulcer disease
  • 15.2. Osteoporosis
  • 15.3. Previous TB
  • 15.4. Glaucoma
  • 15.5. No previous chickenpox AND known recent (<=28 days) history of close personal contact with chickenpox OR herpes zoster
  • 15.6. Suspected ocular herpes simplex
  • 15.7. Cushing's disease
  • 15.8. Epilepsy
  • 15.9. Known allergy to prednisolone or other OS

研究者

发起方
niversity of Bristol (UK)

相似试验